These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 19275564)

  • 1. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
    Bustamante C; Batista CN; Zalis M
    Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs.
    Choi SR; Mukherjee P; Avery MA
    Curr Med Chem; 2008; 15(2):161-71. PubMed ID: 18220771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.
    Gama BE; Lacerda MV; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():159-66. PubMed ID: 21881770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria historians: analyze your old slides!
    Sibley CH
    Trends Parasitol; 2006 Jun; 22(6):243-4. PubMed ID: 16632405
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-oxopurine phosphoribosyltransferase: a target for the development of antimalarial drugs.
    de Jersey J; Holý A; Hocková D; Naesens L; Keough DT; Guddat LW
    Curr Top Med Chem; 2011; 11(16):2085-102. PubMed ID: 21619515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-resistant malaria in children and in travelers.
    Longworth DL
    Pediatr Clin North Am; 1995 Jun; 42(3):649-64. PubMed ID: 7761145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.
    Mason DP; McKenzie FE
    Am J Trop Med Hyg; 1999 Sep; 61(3):367-74. PubMed ID: 10497972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
    Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
    Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antimalarial ferroquine: from bench to clinic.
    Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
    Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A database of antimalarial drug resistance.
    Sibley CH; Ringwald P
    Malar J; 2006 Jun; 5():48. PubMed ID: 16774688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human malaria-
    Obaldía N
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0033824. PubMed ID: 38837364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The current status of the resistance of malaria pathogens to antimalarials].
    Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV
    Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea.
    Barnadas C; Senn N; Iga J; Timinao L; Javati S; Malau E; Rarau P; Reeder JC; Siba P; Karunajeewa H; Zimmerman PA; Davis TM; Mueller I
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6958-61. PubMed ID: 25155586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
    Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
    Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.
    Mishra N; Srivastava B; Bharti RS; Rana R; Kaitholia K; Anvikar AR; Das MK; Ghosh SK; Bhatt RM; Tyagi PK; Dev V; Phookan S; Wattal SL; Sonal GS; Dhariwal AC; Valecha N
    J Vector Borne Dis; 2016; 53(2):168-78. PubMed ID: 27353588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?].
    Kroeger A
    Rev Panam Salud Publica; 2001 Mar; 9(3):202-4. PubMed ID: 11349355
    [No Abstract]   [Full Text] [Related]  

  • 20. Can estimates of antimalarial efficacy from field studies be improved?
    Gatton ML; Cheng Q
    Trends Parasitol; 2008 Feb; 24(2):68-73. PubMed ID: 18182325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.